Membranous glomerulonephritis

Journal of the American Society of Nephrology

Volumn 8, Issue 4, 1997, Pages 664-674

  Wassertein, Alan G ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE;

HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; REVIEW;

EID: 0030722334     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v84664     Document Type: Review

References (45)

1. Burstein DM, Korbet SM, Schwartz MM: Membranous glomerulonephritis and malignancy. Am J Kidney Dis 22: 5-10, 1993
2. Takekoshi Y, Tochimaru H, Nagata Y, Itami N: Immunopathogenetic mechanisms of hepatitis virus-related glomerulopathy. Kidney Int 40[Suppl 35]: S34-S39, 1991
3. Yoshikawa N, Ito H, Yamada Y, Hashimoto H, Katayama Y, Matsuyama S, Hasegawa O, Okada S, Hajikano H, Yoshizawa H: Membranous glomerulonephritis associated with hepatitis B antigen in children: A comparison with idiopathic membranous glomerulonephritis. Clin Nephrol 23: 28-34, 1985
4. Radford MG, Holley KE, Grande JP, Larson TS, Wagoner RD, Donadio JV, McCarthy JT: Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. JAMA 276: 466-469, 1996
5. Ehrenreich T, Churg J: Pathology of membranous nephropathy. In: Pathology Annual, edited by Sommers SC, Norwalk, Appleton-Century Crofts, 1968, pp 145-186
6. Davenport A, Maciver AG, Hall CL, MacKenzie JC: Do mesangial immune complex deposits affect the renal prognosis in membranous glomerulonephritis? Clin Nephrol 41: 271-276, 1994
7. Jennette JC, Iskandar SS, Dalldorf FG: Pathological differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int 24: 377-385, 1983
8. Farquhar MG, Saito A, Kerjaschki D, Orlando RA: The Heymann nephritis antigenic complex: Megalin (gp330) and RAP. J Am Soc Nephrol 6: 35-47, 1995
9. Austin HA III, Antonovych TT, MacKay K, Boumpas DT, Balow JE: Membranous nephropathy. Ann Intern Med 116: 672-682, 1992
10. Fries JWU, Mendrick DL, Rennke HG: Determinants of immune complex-mediated glomerulonephritis. Kidney Int 34: 333-345, 1988
11. Donadio JV Jr, Torres V, Velosa JA, Wagoner RD, Holley KE, Okamura M, Ilstrup DM, Chu CP: Idiopathic membranous nephropathy: The natural history of untreated patients. Kidney Int 33: 708-715, 1988
12. Brenchley PE, Coupes B, Short CD, O'Donoghue DJ, Ballardie FW, Mallick NP: Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy. Kidney Int 41: 933-937, 1992
13. Kon SP, Coupes B, Short CD, Solomon LR, Raftery MJ, Mallick NP, Brenchley PE: Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy. Kidney Int 48: 1953-1958, 1995
14. Katz A, Fish AJ, Santamaria P, Nevins TE, Kim Y, Butkowski RJ: Role of antibodies to tubulointerstitial nephritis antigen in human anti-tubular basement membrane nephritis associated with membranous nephropathy. Am J Med 93: 691-698, 1992
15. James SH, Lien Y-H H, Ruffenach SJ, Wilcox GE: Acute renal failure in membranous glomerulopathy: A result of superimposed crescentic glomerulonephritis. J Am Soc Nephrol 6: 1541-1546, 1995
16. Sarasin F, Schifferli J: Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy (IMN). Kidney Int 45: 578-585, 1994
17. Glassock RJ: Therapy of idiopathic nephrotic syndrome: A conservative or aggressive therapeutic approach. Am J Nephrol 13: 422-428, 1993
18. Sloan RP, Schwartz MM, Korbet SM, Borok RZ: Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. J Am Soc Nephrol 7: 299-305, 1996
19. Davison AM, Cameron JS, Kerr DN, Ogg CS, Wilkinson RW: The natural history of renal function in untreated membranous glomerulonephritis in adults. Clin Nephrol 22: 61-67, 1984
20. Hogan SL, Muller KE, Jennette CJ, Falk RJ: A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 25: 862-875, 1995
21. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C, et al: A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 48: 1600-1604, 1995
22. Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G: Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 329: 85-89, 1993
23. Passerini P, Pasquali S, Cesana B, Zucchelli P, Ponticelli C: Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria. Nephrol Dial Transplant 4: 525-529, 1989
24. Cameron JS: Membranous nephropathy still a treatment dilemma. N Engl J Med 327: 638-639, 1992
25. Pei Y, Cattran D, Greenwood C: Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 42: 960-966, 1992
26. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome: A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 301: 1301-1306, 1979
27. Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S: A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 320: 210-215, 1989
28. Cameron JS, Healy MJR, Adu D, and the MRC Glomerulonephritis Working Party: The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. Q J Med 74: 133-156, 1990
29. Glassock RJ: The therapy of membranous glomerulonephritis. Semin Nephrol 11: 138-147, 1991
30. Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B: A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320: 8-13, 1989
31. Imperiale TF, Goldfarb S, Berns JS: Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials. J Am Soc Nephrol 5: 1553-1558, 1995
32. Falk RJ, Hogan SL, Muller KE, Jennette JC: Treatment of progressive membranous glomerulopathy: A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. Ann Intern Med 116: 438-445, 1992
33. Reichert LJM, Huysmans FTM, Assmann K, Koene RA, Wetzels JF: Preserving renal function in patients with membranous nephropathy: Daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide. Ann Intern Med 121: 328-333, 1994
34. Bruns FJ, Adler S, Fraley DS, Segel DP: Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone. Ann Intern Med 114: 725-730, 1991
35. Warwick GL, Geddes CG, Boulton-Jones JM: Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure. Q J Med 87: 223-229, 1994
36. Short CD, Solomon LR, Gokal R, Mallick NP: Methylprednisolone in patients with membranous nephropathy and declining renal function. Q J Med 65: 929-940, 1987
37. Ponticelli C, Zucchelli P, Passerini P, Cesana B: Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med 327: 599-603, 1992
38. Hebert LA: Therapy of membranous nephropathy: What to do after the after (meta) analyses. J Am Soc Nephrol 5: 1543-1545, 1995
39. Reichert LJM, Koene RAP, Wetzels JFM: Urinary excretion of β2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy. J Am Soc Nephrol 6: 1666-1669, 1995
40. Jindal K, West M, Bear R, Goldstein M: Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function. Am J Kidney Dis 19: 61-67, 1992
41. Passerini P, Como G, Vigano E, Melis P, Pozzi C, Altieri P, Ponticelli C: Idiopathic membranous nephropathy in the elderly. Nephrol Dial Transplant 8: 1321-1325, 1993
42. Guasch A, Suranyi M, Newton L, Hall BM, Myers BD: Short-term responsiveness of membranous glomerulopathy to cyclosporine. Am J Kidney Dis 20: 472-481, 1992
43. Cattran DC, Greenwood C, Ritchie S, Bernstein K, Churchill DN, Clark WF, Morrin PA, Lavoie S: A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int 47: 1130-1135, 1995
44. Praga M, Hernandez E, Montoyo C, Andres A, Ruilope LM, Rodicio JL: Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 20: 240-248, 1992
45. Lai KN, Tam JS, Lin HJ, Lai FM: The therapeutic dilemma of usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenemia. Nephron 54: 12-17, 1990